Kevin Herbert Sells Shares of Nature's Sunshine Products

Executive Kevin Herbert sold 2,000 shares of Nature's Sunshine on June 12, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 2:03 AM EDT · Updated Jun 16, 2026, 1:01 PM EDT

Key Points

Kevin Herbert, EVP & President, North America at Nature's Sunshine Products, sold 2,000 shares on June 12, 2026, at an average price of $20.682, totaling $41,364.
Nature's Sunshine stock traded at $20.04 with a market cap of $352.4 million, a P/E ratio of 18.2, and a 52-week range between $12.97 and $28.14.
Recent analyst activity includes DA Davidson maintaining a 'buy' rating with a $33 target, and notable institutional holdings adjustments by BlackRock and Kennedy Capital Management.

Kevin Herbert, the Executive Vice President and President of North America at Nature's Sunshine Products, Inc. (NasdaqCM: NATR), sold 2,000 shares of the company on June 12, 2026. The shares were sold at an average price of $20.682, bringing the total transaction value to $41,364. This sale was not part of a pre-planned trading program.

Insider Buying and Selling at Nature's Sunshine Products, Inc.

In addition to Kevin Herbert's recent sale, other executives have also been active. On June 5, 2026, Bryant Yates, EVP & President of Europe, sold 11,968 shares at $19.90. Earlier, on June 1, 2026, Daniel Norman, EVP & President of Asia, sold 9,713 shares at $20.64. Notably, Steven Fasching and Rong Yang each bought 4,500 shares on May 15, 2026, though the purchase price was not disclosed.

Other Institutional Activity in Nature's Sunshine Products

Several institutional investors have adjusted their positions in Nature's Sunshine Products. BlackRock, Inc. reduced its holdings by 55,860 shares, ending with 1,064,454 shares valued at approximately $25.5 million. On the other hand, Kennedy Capital Management LLC increased its stake by 15,880 shares, now holding 691,498 shares worth $16.6 million. Meanwhile, Acadian Asset Management LLC added 26,768 shares, bringing its total to 657,805 shares valued at $15.8 million.

Nature's Sunshine Products Stock Snapshot

Shares of Nature's Sunshine Products traded at $20.04. The company holds a market cap of about $352.4 million and a P/E ratio of 18.2. Its stock has seen a 52-week low of $12.97 and a high of $28.14, with a 50-day moving average of $23.81 and a 200-day moving average of $21.53. The firm maintains a current ratio of 2.50 and a quick ratio of 1.40, with a debt-to-equity ratio of 13.44.

Analysts Set New Price Targets

On May 11, 2026, DA Davidson maintained a 'buy' rating on Nature's Sunshine with a price target of $33. Canaccord Genuity also kept a 'buy' rating, setting a target of $33 on March 11, 2026. The consensus among analysts is a 'buy' rating, with a mean price target of $35, based on two analyst opinions.

About Nature's Sunshine Products

Nature's Sunshine Products, Inc. is a company based in Lehi, Utah, specializing in the manufacture and sale of nutritional and personal care products. Founded in 1972, the company operates in the Consumer Defensive sector, particularly in the Packaged Foods industry. It offers a variety of products under the Nature's Sunshine and Synergy Worldwide brands, distributed through a network of independent consultants across Asia, Europe, North America, and Latin America. The company is led by CEO Mr. Kenneth G. Romanzi and employs around 806 people.

Bottom Line

Kevin Herbert's sale of shares is part of a broader trend of insider transactions at Nature's Sunshine Products. Investors keep an eye on such moves as they can provide insights into executives' perspectives on the company's future. While insiders are selling, institutional investors like Kennedy Capital are increasing their positions, indicating varied outlooks. As always, it's crucial to remember that insider transactions are just one piece of the puzzle when evaluating a company's stock.